• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部鳞状细胞癌的结构化早期随访:一项回顾性队列研究。

Structured Early Follow-Up in Head and Neck Squamous Cell Carcinomas: A Retrospective Cohort Study.

作者信息

Dittmann Philipp, Lehnert Bernhard, Ihler Friedrich, Busch Chia-Jung, Blaurock Markus

机构信息

Klinik für Mund- Kiefer- Gesichtschirurgie, Plastische Operationen, Universitätsmedizin Greifswald, 17489 Greifswald, Germany.

Klinik für Hals-, Nasen-, Ohrenkrankheiten, Kopf- und Halschirurgie, Universitätsmedizin Greifswald, 17489 Greifswald, Germany.

出版信息

Biomedicines. 2025 May 20;13(5):1246. doi: 10.3390/biomedicines13051246.

DOI:10.3390/biomedicines13051246
PMID:40427073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12109110/
Abstract

The various head and neck squamous cell carcinoma (HNSCC) subtypes are among the most common cancers globally, with significant recurrence rates within the first two years post-treatment. Despite advancements in treatment, structured early follow-up remains crucial for timely diagnosis and effective salvage treatment. : This retrospective study examines the impact of implementing a structured initial restaging between three and six months after the conclusion of initial treatment. The study population included 532 patients treated with curative intent at the University Medicine of Greifswald, Germany, between 2010 and 2019. Patients were divided into two groups: standard follow-up (SF) and adapted follow-up (AF). The AF group received standardized post-treatment restaging, including imaging and panendoscopy or PET-CT exams. : We found a trend towards earlier diagnosis and a reduction in recurrences, although these differences were not statistically significant. Secondary cancers were observed more frequently in the AF group, significantly affecting overall survival. : Our cohort supports structured initial cancer follow-up in HNSCC. Although not significant, an initial multimodal exam after treatment was well tolerated and showed a trend toward earlier diagnosis.

摘要

各种头颈鳞状细胞癌(HNSCC)亚型是全球最常见的癌症之一,在治疗后的头两年内复发率很高。尽管治疗取得了进展,但结构化的早期随访对于及时诊断和有效的挽救治疗仍然至关重要。本回顾性研究探讨了在初始治疗结束后三到六个月进行结构化初始再分期的影响。研究人群包括2010年至2019年期间在德国格赖夫斯瓦尔德大学医学中心接受根治性治疗的532例患者。患者分为两组:标准随访(SF)组和适应性随访(AF)组。AF组接受标准化的治疗后再分期,包括影像学检查和全内镜检查或PET-CT检查。我们发现有早期诊断的趋势以及复发率降低,尽管这些差异无统计学意义。AF组中继发性癌症的观察更为频繁,显著影响总体生存率。我们的队列研究支持HNSCC的结构化初始癌症随访。尽管不显著,但治疗后的初始多模式检查耐受性良好,并显示出早期诊断的趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/75329d75fc7e/biomedicines-13-01246-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/e5aa22a7dcf6/biomedicines-13-01246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/a9ea5246d3c9/biomedicines-13-01246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/3d9f604b9ef5/biomedicines-13-01246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/d8c7ef0204c8/biomedicines-13-01246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/379689bac835/biomedicines-13-01246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/75329d75fc7e/biomedicines-13-01246-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/e5aa22a7dcf6/biomedicines-13-01246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/a9ea5246d3c9/biomedicines-13-01246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/3d9f604b9ef5/biomedicines-13-01246-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/d8c7ef0204c8/biomedicines-13-01246-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/379689bac835/biomedicines-13-01246-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfda/12109110/75329d75fc7e/biomedicines-13-01246-g006.jpg

相似文献

1
Structured Early Follow-Up in Head and Neck Squamous Cell Carcinomas: A Retrospective Cohort Study.头颈部鳞状细胞癌的结构化早期随访:一项回顾性队列研究。
Biomedicines. 2025 May 20;13(5):1246. doi: 10.3390/biomedicines13051246.
2
An Intensive 18F-Fludeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Strategy of Follow-Up in Patients Treated for Head and Neck Squamous Cell Carcinoma Who Are Clinically Asymptomatic.在临床无症状的头颈部鳞状细胞癌患者中,采用基于 18F-氟脱氧葡萄糖正电子发射断层扫描与计算机断层扫描的强化随访策略。
JAMA Netw Open. 2023 Aug 1;6(8):e2326654. doi: 10.1001/jamanetworkopen.2023.26654.
3
Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.对于口咽和下咽局部晚期鳞状细胞癌,在进行根治性放化疗后进行计划中的再分期和早期手术挽救的生存影响。
Am J Clin Oncol. 2005 Aug;28(4):385-92. doi: 10.1097/01.coc.0000162422.92095.9e.
4
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment.治疗结束后 6 个月时 FDG PET/CT 探测头颈部鳞状细胞癌亚临床复发的诊断性能。
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):72-8. doi: 10.1007/s00259-014-2889-1. Epub 2014 Aug 29.
5
Diagnostic Performance of F-FDG PET/CT According to Delay After Treatment to Detect Subclinical Recurrence of Head and Neck Squamous Cell Carcinoma.基于治疗后延迟时间的 F-FDG PET/CT 诊断性能检测头颈部鳞状细胞癌的亚临床复发。
J Nucl Med. 2024 Aug 1;65(8):1181-1187. doi: 10.2967/jnumed.124.267391.
6
Combined Spatial and Dosimetric Recurrence Pattern Analysis in Head and Neck Squamous Cell Carcinoma Following Postoperative (Chemo)radiotherapy.头颈部鳞状细胞癌术后(化疗)放疗后的联合空间与剂量学复发模式分析
Radiat Oncol. 2025 Apr 23;20(1):63. doi: 10.1186/s13014-025-02641-8.
7
FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.氟代脱氧葡萄糖正电子发射断层显像/增强CT作为头颈部鳞状细胞癌的治疗后评估工具:与氟代脱氧葡萄糖正电子发射断层显像/非增强CT及增强CT的比较
Eur Radiol. 2016 Apr;26(4):1018-30. doi: 10.1007/s00330-015-3902-1. Epub 2015 Jul 19.
8
Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.头颈部鳞状细胞癌的局部区域肿瘤评估:MRI、PET/CT与PET/MRI一体化成像的比较
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):92-102. doi: 10.1007/s00259-015-3145-z. Epub 2015 Aug 6.
9
Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)早期发现复发性疾病可导致头颈部鳞状细胞癌患者的治疗方式发生改变。
Oncologist. 2013;18(10):1108-17. doi: 10.1634/theoncologist.2013-0068. Epub 2013 Sep 13.
10
3-year overall survival benefit of systematic follow-up with 18F-FDG PET/CT in asymptomatic patients treated for head and neck squamous cell carcinoma: a multicenter study.18F-FDG PET/CT系统随访对无症状头颈鳞状细胞癌患者的3年总生存获益:一项多中心研究
Eur J Nucl Med Mol Imaging. 2025 Feb 26. doi: 10.1007/s00259-025-07147-9.

本文引用的文献

1
The intersection of travel burdens and financial hardship in cancer care: a scoping review.癌症护理中旅行负担和经济困难的交集:范围综述。
JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae093.
2
Longer-term surveillance imaging and endoscopy critical for majority of patients in detection of sinonasal malignancy recurrence.长期监测成像和内窥镜检查对大多数鼻鼻窦恶性肿瘤复发检测患者至关重要。
Int Forum Allergy Rhinol. 2024 Nov;14(11):1739-1745. doi: 10.1002/alr.23412. Epub 2024 Jul 22.
3
Separating distant recurrences from second primaries in head and neck squamous cell carcinomas - A DAHANCA group analysis on paired tumor samples.
头颈部鳞状细胞癌中远处复发与第二原发肿瘤的区分 - DAHANCA 研究组对配对肿瘤样本的分析。
Head Neck. 2024 Oct;46(10):2532-2539. doi: 10.1002/hed.27750. Epub 2024 Mar 25.
4
Post-treatment surveillance imaging in head and neck cancer: a systematic review.头颈部癌的治疗后监测成像:一项系统综述
Insights Imaging. 2024 Feb 5;15(1):32. doi: 10.1186/s13244-023-01578-4.
5
The Diagnostic Performance of Multiparametric Ultrasound in the Qualitative Assessment of Inconclusive Cervical Lymph Nodes.多参数超声在定性评估不确定颈部淋巴结中的诊断性能
Cancers (Basel). 2023 Oct 18;15(20):5035. doi: 10.3390/cancers15205035.
6
Initial Cancer Treatment in Certified Versus Non-Certified Hospitals.认证医院与非认证医院的癌症初始治疗。
Dtsch Arztebl Int. 2023 Sep 29;120(39):647-654. doi: 10.3238/arztebl.m2023.0169.
7
Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.头颈部鳞状细胞癌复发模式,为制定个体化监测方案提供信息。
Cancer. 2023 Sep 15;129(18):2817-2827. doi: 10.1002/cncr.34823. Epub 2023 May 10.
8
Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma.液体活检用于头颈部鳞状细胞癌微小残留病灶检测(LIONESS)——头颈部鳞状细胞癌个体化循环肿瘤 DNA 分析
Br J Cancer. 2022 May;126(8):1186-1195. doi: 10.1038/s41416-022-01716-7. Epub 2022 Feb 7.
9
Safe Delivery of Surgical Care in Head and Neck Cancer Patients During COVID-19-an Audit of Pattern of Presentation and Treatment Strategies in an Oncology Centre in the Northern India.COVID-19期间头颈癌患者手术治疗的安全实施——印度北部一家肿瘤中心的就诊模式与治疗策略审计
Indian J Surg Oncol. 2021 Dec;12(Suppl 2):250-256. doi: 10.1007/s13193-021-01399-1. Epub 2021 Jul 30.
10
The risk of second primary tumors in head and neck cancer: A systematic review.头颈部癌患者发生第二原发性肿瘤的风险:一项系统评价。
Head Neck. 2020 Mar;42(3):456-466. doi: 10.1002/hed.26016. Epub 2019 Nov 21.